Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://amieejkx201531.dm-blog.com/39150804/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment